INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 43 filers reported holding INFLARX NV in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,052,040 | +221.1% | 688,604 | +97.0% | 0.25% | +194.0% |
| Q1 2022 | $639,000 | -59.5% | 349,468 | +5.6% | 0.08% | -64.3% |
| Q4 2021 | $1,577,000 | -3.5% | 331,048 | -47.5% | 0.24% | +104.3% |
| Q3 2021 | $1,634,000 | -17.5% | 631,048 | -5.3% | 0.12% | -28.1% |
| Q2 2021 | $1,980,000 | -27.4% | 666,596 | -4.7% | 0.16% | +73.9% |
| Q1 2021 | $2,729,000 | +261.9% | 699,750 | +367.3% | 0.09% | +178.8% |
| Q4 2020 | $754,000 | +18.4% | 149,750 | 0.0% | 0.03% | -28.3% |
| Q3 2020 | $637,000 | -9.0% | 149,750 | -1.9% | 0.05% | -17.9% |
| Q2 2020 | $700,000 | -30.2% | 152,600 | -41.9% | 0.06% | -25.3% |
| Q1 2020 | $1,003,000 | -29.5% | 262,600 | -26.9% | 0.08% | -67.4% |
| Q4 2019 | $1,422,000 | – | 359,128 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,766,038 | $56,955,000 | 17.85% |
| RA Capital Management | 1,967,148 | $63,441,000 | 4.12% |
| Cormorant Asset Management, LP | 1,487,265 | $47,964,000 | 3.55% |
| Redmile Group, LLC | 2,027,700 | $65,393,000 | 2.22% |
| EMORY UNIVERSITY | 77,554 | $2,501,000 | 1.66% |
| Eventide Asset Management | 275,000 | $8,869,000 | 0.37% |
| Birchview Capital, LP | 16,000 | $516,000 | 0.35% |
| Artal Group S.A. | 500,000 | $16,125,000 | 0.34% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 2,385,659 | $76,938,000 | 0.18% |
| Baker Brothers Advisors | 258,824 | $8,347,000 | 0.06% |